Subscribe for the newsletter
Sign in
Articles
Expert Interviews
Roundtable
Press Releases
Videos
The Road To Series
Market Research
Directory
More
Discovery
Small Molecules
Biologics
Advanced Therapies
Manufacturing
Supply Chain
Clinical Trials
Technologies
Financing
Discovery
Filter
Filter
Sort By
Newest First
Sector
Modality / Product
Reset
1 / 16
1 / 16
Rare Disease
Rare Disease Biotech Announces ‘Hugely Significant’ Milestone with Selection of Candidate Drug
SynaptixBio
PR-06-25-NI-02
Jun 10, 2025
Fundraising
Sano Women’s Health Raises Funds to Advance Phase 2 Clinical Trials for Novel RVVC Treatment
Sano Women's Health
PR-06-25-NI-01
Jun 06, 2025
Degradation
Beyond the Proteasome: Unlocking New Frontiers with AUTACs and LYTACs
David Alvaro, Ph.D.
Pharma's Almanac
PAO-06-25-NI-01
Jun 02, 2025
Neuroscience
Designer Control: DREADDs and the Next Generation of Targeted Neuromodulation
David Alvaro, Ph.D.
Pharma's Almanac
PAO-05-25-NI-11
May 29, 2025
Nanobodies
Therapeutic Nanobodies and Intrabodies Rewriting the Rules of Target Engagement
David Alvaro, Ph.D.
Pharma's Almanac
PAO-05-25-NI-10
May 27, 2025
Protein Design
Reprogramming the Rules: How AI Is Transforming De Novo Protein Design in Drug Development
David Alvaro, Ph.D.
Pharma's Almanac
PAO-04-25-NI-08
Apr 15, 2025
First-in-Class Drugs
Breaking New Ground: 30 Years of First-in-Class Drug Innovation
Cynthia A. Challener, Ph.D.
Pharma's Almanac
PAO-25-30-27
Apr 09, 2025
Maternal Health
Maternal Mandate: Elevating Innovation, Equity, and Investment in Women’s Health
David Alvaro, Ph.D.
Pharma's Almanac
PAO-04-25-NI-04
Apr 08, 2025
Microbiome
Innovating to Target the Microbiome for Human Health
Servatus
PAO-11-24-RTM-15
Apr 08, 2025
Spintronics
Spintronics and the Future of Drug Design
David Alvaro, Ph.D.
Pharma's Almanac
PAO-04-25-NI-03
Apr 04, 2025
Psychedelics
Unlocking the Potential of Psychedelics for Postpartum Depression
Greg Mayes, J.D.
Reunion Neuroscience
PAO-03-25-CL-05
Mar 31, 2025
Drug Approvals
How can the industry balance the need for faster drug approvals with the necessity of ensuring patient safety and efficacy?
Pharma's Almanac
PAO-03-25-RT-01
Mar 26, 2025
Magnetogenetics
Magnetogenetics and the Future of Remote Biological Control
David Alvaro, Ph.D.
Pharma's Almanac
PAO-03-25-NI-04
Mar 17, 2025
Advocacy
From Patients to Partners: The Rising Power of Advocacy in Drug Development
David Alvaro, Ph.D.
Pharma's Almanac
PAO-25-30-19
Mar 13, 2025
Biomarkers
The Biomarker Revolution in Medicine and Drug Development
David Alvaro, Ph.D.
Pharma's Almanac
PAO-25-30-16
Mar 10, 2025
HTS
The High-Throughput Screening Transformation in Modern Drug Development
David Alvaro, Ph.D.
Pharma's Almanac
PAO-25-30-12
Mar 02, 2025
Accelerated Approval
30 Years of Accelerated Approvals: Fast-Tracking Innovation in Drug Development
Cynthia A. Challener, Ph.D.
Pharma's Almanac
PAO-25-30-07
Mar 02, 2025
Structural Biology
The Disruptive Impact of Structural Biology on Biopharmaceutical Innovation
David Alvaro, Ph.D.
Pharma's Almanac
PAO-25-30-13
Mar 02, 2025
Real-World Evidence
Overcoming Challenges and Unlocking the Potential of Real-World Evidence
David Alvaro, Ph.D.
Pharma's Almanac
PAO-25-30-09
Mar 02, 2025
Cannabinoids
Unlocking New Frontiers with Cannabinoid and Psychedelic Therapies
David Alvaro, Ph.D.
Pharma's Almanac
PAO-25-30-04
Mar 02, 2025
